VishaySIA519EDJ-T1-GE3MOSFETs
Trans MOSFET N/P-CH 20V 4.5A 6-Pin PowerPAK SC-70 EP T/R
| Compliant | |
| EAR99 | |
| Active | |
| COMPONENTS | |
| Automotive | No |
| PPAP | No |
| Power MOSFET | |
| Dual | |
| 0.18um | |
| Enhancement | |
| N|P | |
| 2 | |
| 20 | |
| ±12 | |
| 1.4@N Channel|1.3@P Channel | |
| -55 to 150 | |
| 4.5 | |
| 90000@N Channel|8000@P Channel | |
| 1 | |
| 40@4.5V@N Channel|90@4.5V@P Channel | |
| 7.7@10V|3.7@4.5V@N Channel|10.5@10V|5.3@4.5V@P Channel | |
| 7.7@N Channel|10.5@P Channel | |
| 0.95@N Channel|2@P Channel | |
| 0.85@N Channel|0.75@P Channel | |
| 8@N Channel|13@P Channel | |
| 350@10V@N Channel|340@10V@P Channel | |
| 50@10V@N Channel|95@10V@P Channel | |
| 0.6@N Channel|0.5@P Channel | |
| 82@N Channel|105@P Channel | |
| 1900 | |
| 16@N Channel|10@P Channel | |
| 12@N Channel|20@P Channel | |
| 21@N Channel|25@P Channel | |
| 10@N Channel|20@P Channel | |
| -55 | |
| 150 | |
| Tape and Reel | |
| 32@4.5V|53@2.5V@N Channel|74@4.5V|113@2.5V@P Channel | |
| 1.9 | |
| 15 | |
| 110 | |
| 0.8 | |
| 1.95@N Channel|1.75@P Channel | |
| 15@N Channel|26@P Channel | |
| 1.2 | |
| 0.7@N Channel|0.2@P Channel | |
| 7@N Channel|20@P Channel | |
| 12 | |
| 4.5@N Channel|3.7@P Channel | |
| Mounting | Surface Mount |
| Package Height | 0.73 |
| Package Width | 2.05 |
| Package Length | 2.05 |
| PCB changed | 6 |
| Supplier Package | PowerPAK SC-70 EP |
| 6 |
Thanks to Vishay, both your amplification and switching needs can be taken care of with one component: the SIA519EDJ-T1-GE3 power MOSFET. Its maximum power dissipation is 1900 mW. This product will be shipped in tape and reel packaging so that components can be mounted effectively. This device is made with TrenchFET technology. This N|P channel MOSFET transistor operates in enhancement mode. This MOSFET transistor has a minimum operating temperature of -55 °C and a maximum of 150 °C.
| EDA / CAD Models |
Design AI-powered medical devices
Explore system design tips, part recs and AI insights to help you build faster, safer diagnostic and therapy solutions—all in Arrow’s latest white paper.